Literature DB >> 26017077

Hepatitis B in Rondônia (Western amazon region, Brazil): descriptive analysis and spatial distribution.

Gabriel de Deus Vieira1, Mayara Florão1, Karen Priscilla Oliveira Castro1, Thaianne da Cunha Alves1, Spencer Vaiciunas1, Eduardo Rezende Honda1, Luís Marcelo Aranha Camargo1, Camila Maciel de Sousa1.   

Abstract

BACKGROUND: The Amazon is one of the regions who have the highest rates of infection by the hepatitis B virus in the world. Objectives This study aimed to evaluate the epidemiological data and spatial distribution of hepatitis B cases reported between 2002 and 2012 in the Brazilian State of Rondônia.
METHODS: Social and clinical data of these individuals were studied through the Information System for Notifiable Diseases (SINAN), including the following variables: gender, age group, vaccination, contact with a known patient with HBV, exposure to risk factors, source of infection, and clinical status.
RESULTS: There were 7,132 cases reported in Rondônia, with an average incidence rate of 42/100,000 inhabitants per year. The municipalities with the highest incidence rates were Monte Negro (187.6/100,000 inhabitants) and Ariquemes (157.2/100,000 inhabitants). The 20-39 year-old age group had the highest number of cases (n = 3,834), and 69.9% of patients were likely infected via sexual contact. Regarding the clinical disease status, most of the patients (80.7%) were in the chronic phase.
CONCLUSIONS: There was a recent 402% increase in the diagnosis of hepatitis B, which is likely owing to the improvements in the public diagnostic system. This highlights the need for public policies to prevent and control the disease.

Entities:  

Mesh:

Year:  2015        PMID: 26017077     DOI: 10.1590/S0004-28032015000100005

Source DB:  PubMed          Journal:  Arq Gastroenterol        ISSN: 0004-2803


  1 in total

1.  Clinical, epidemiological aspects, and trends of Hepatitis B in Brazil from 2007 to 2018.

Authors:  Cathianne Sacramento Pinto; Galileu Barbosa Costa; Ivan Bezerra Allaman; Sandra Rocha Gadelha
Journal:  Sci Rep       Date:  2021-07-07       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.